title: Should elderly cancer patients be entered in dose-escalation studies?
authors.forename: S
authors.initials: S
authors.lastname: Monfardini
authors.forename: R
authors.initials: R
authors.lastname: Sorio
authors.forename: S
authors.initials: S
authors.lastname: Kaye
mesh_terms: D000367:Age Factors; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017321:Clinical Trials, Phase I as Topic; D006801:Humans; D018579:Patient Selection
chemical_list: D000970:Antineoplastic Agents